Edwards Lifesciences Corporation (EW) Q1 2012 Earnings Results

Edwards Lifesciences Beats on EPS, Stock Down 0.04%

Edwards Lifesciences reported a better-than-expected EPS, which indicates strong profitability. However, the stock reacted slightly negatively, down 0.04%, possibly due to the lack of revenue data and guidance. Investors may be cautious as they await more comprehensive financial details in future reports.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.55	N/A	+15.06%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding their performance. They emphasized their commitment to growth and innovation.

Management expressed satisfaction with the EPS performance despite not providing revenue figures.

They highlighted ongoing efforts to innovate and expand their product offerings.

Edwards Lifesciences Beats on EPS, Stock Down 0.04%

Key numbers

Management commentary

Edwards Lifesciences Corporation

More earnings this week

Edwards Lifesciences Beats on EPS, Stock Down 0.04%

Key numbers

Management commentary